Types and Clinical Descriptions of Acne
Acne vulgaris presents with distinct lesion types including open comedones (blackheads), closed comedones (whiteheads), inflammatory papules, pustules, and nodules, primarily affecting the face and trunk, with potential sequelae of pain, erythema, hyperpigmentation, and scarring. 1
Primary Lesion Types
Non-Inflammatory Lesions
- Comedones represent the foundational lesions of acne, arising from follicular hyperkeratinization and sebaceous duct obstruction 1, 2
- Open comedones (blackheads): Dilated follicular openings with visible dark keratin plugs 1
- Closed comedones (whiteheads): Obstructed follicles without visible surface opening 1
- At the ultrastructural level, comedonal keratinocytes demonstrate increased desmosomes and tonofilaments causing ductal hypercornification 2
Inflammatory Lesions
- Papules: Small, raised, erythematous lesions resulting from perifollicular inflammation 1, 3
- Pustules: Papules with visible purulent centers containing neutrophils and macrophages that infiltrate around hair follicles 1, 2
- Nodules: Deep, painful, solid lesions extending into the dermis, representing severe inflammatory acne 1
- Cysts: Severe inflammatory lesions that can lead to significant scarring 3
Anatomic Distribution
- Face: Most common site, with cheeks being the predominant location (85% of cases) 4
- Trunk: Includes chest and back involvement, with distinct pathophysiological features including thicker stratum corneum, lower sebaceous gland density, and site-specific microbiota differences 1, 5
- Truncal acne tends to present with deeper, more extensive lesions due to clothing occlusion and friction 5
Secondary Changes and Sequelae
Post-Inflammatory Changes
- Erythema: Persistent redness following inflammatory lesion resolution 1, 6
- Hyperpigmentation: More prevalent in darker skin types, affecting 65% of African American and 48% of Hispanic patients compared to 10-25% in other ethnicities 7
- Dyspigmentation: Particularly common in African American and Hispanic populations 7
Scarring
- Atrophic scarring: More common in African American and Hispanic patients 7
- Facial scarring occurs in 62.8% of adult acne patients, emphasizing the importance of early intervention 4
- Scarring represents a key indication for aggressive treatment including oral isotretinoin 1
Clinical Severity Classification
The American Academy of Dermatology consensus established a 5-point ordinal scale (0-4) for severity grading 1:
- 0: Clear
- 1: Almost clear
- 2: Mild
- 3: Moderate
- 4: Severe
The Investigator Global Assessment (IGA) is the most commonly used grading system in the United States, demonstrating good agreement between clinician and patient ratings 1. An ideal grading system should measure primary lesion types, lesion counts, extent and region of involvement, and possess strong psychometric properties 1
Clinical Variants by Demographics
Adult Acne (Acne Tarda)
- Defined as acne occurring in individuals aged 25 years and older 6
- Persistent type (68.3%): Acne continuing from adolescence into adulthood 4
- Late-onset type: New acne developing in adulthood 6
- Inflammatory papular acne (72.8%) is the most common morphology in adults 4
- Female predominance (81.7% of adult cases) with premenstrual flare in 61.9% 4
Ethnic Variations
- Clinical acne prevalence is higher in African American (37%) and Hispanic (32%) women compared to Continental Indian (23%), Caucasian (24%), and Asian (30%) women 7
- Asians demonstrate higher prevalence of inflammatory versus comedonal acne (20% vs 10%) 7
- Caucasians show higher prevalence of comedonal versus inflammatory acne (14% vs 10%) 7
Pathophysiological Context
The clinical presentation reflects multifactorial pathogenesis involving 1, 2:
- Follicular hyperkeratinization
- Microbial colonization with Cutibacterium acnes (formerly Propionibacterium acnes)
- Increased sebum production stimulated by androgens
- Complex inflammatory mechanisms involving innate and acquired immunity
- Neuroendocrine factors, including stress-induced substance P promoting sebaceous gland proliferation 2